GCM
CELL

Graham Capital Management’s PhenomeX Inc. Common Stock CELL Stock Holding History

Graham Capital Management’s Portfolio CELL Stock Details CELL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-14,739
Closed -$42K – 1435
2022
Q3 		$42K Buy
+14,739
New +$62.7K ﹤0.01% 1032

Other funds holding CELL

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Mackenzie Financial
Mackenzie Financial Toronto Ontario, Ontario, Canada $83.3B AUM 31.19% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
NIMC
Nierenberg Investment Management Company Camas, Washington $201M AUM 36.3% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
GCM
Glenview Capital Management New York $3.98B AUM 20.52% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
MAM
Monaco Asset Management Monaco $542M AUM 54.4% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Graham Capital Management's CELL Position: Q4 2022 in Review

Graham Capital Management sold out of PhenomeX Inc. Common Stock (CELL) in Q4 2022, closing a stake of 14,739 shares — an estimated $42K sold.

Graham Capital Management first reported a position in CELL in Q3 2022 and held it in 1 quarter. The position peaked at $42K in Q3 2022. 117 funds tracked by Wall St. Rank hold CELL as of Q4 2022.

  • Graham Capital Management reported no remaining PhenomeX Inc. Common Stock position as of Q4 2022 after selling out during the quarter.
  • Graham Capital Management sold 14,739 PhenomeX Inc. Common Stock shares in Q4 2022, an estimated $42K.
  • Graham Capital Management first reported a position in PhenomeX Inc. Common Stock in Q3 2022 and held it in 1 quarter.
  • Graham Capital Management's PhenomeX Inc. Common Stock position peaked at $42K in Q3 2022.
  • 117 funds tracked by Wall St. Rank held PhenomeX Inc. Common Stock as of Q4 2022.

Based on Graham Capital Management's 13F filing for Q4 2022, filed 14 Feb 2023.